A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z  

        1 2 3 | Last   [Sort by number of followers]   [Restore default list]

  Subjects -> PHARMACY AND PHARMACOLOGY (Total: 575 journals)
Showing 1 - 200 of 253 Journals sorted alphabetically
AAPS Journal     Hybrid Journal   (Followers: 24)
AAPS Open     Open Access   (Followers: 4)
AAPS PharmSciTech     Hybrid Journal   (Followers: 6)
AboutOpen     Open Access  
ACS Pharmacology & Translational Science     Hybrid Journal   (Followers: 3)
Acta Pharmaceutica     Open Access   (Followers: 4)
Acta Pharmaceutica Indonesia     Open Access  
Acta Pharmaceutica Sinica B     Open Access   (Followers: 1)
Acta Pharmacologica Sinica     Hybrid Journal   (Followers: 3)
Acta Physiologica Hungarica     Full-text available via subscription  
Actualites Pharmaceutiques     Full-text available via subscription   (Followers: 4)
Advanced Drug Delivery Reviews     Hybrid Journal   (Followers: 96)
Advanced Herbal Medicine     Open Access   (Followers: 8)
Advanced Therapeutics     Hybrid Journal   (Followers: 1)
Advances in Pharmacoepidemiology & Drug Safety     Open Access   (Followers: 2)
Advances in Pharmacological and Pharmaceutical Sciences     Open Access   (Followers: 9)
Advances in Pharmacology     Full-text available via subscription   (Followers: 18)
Advances in Pharmacology and Pharmacy     Open Access   (Followers: 5)
Advances in Traditional Medicine     Hybrid Journal   (Followers: 3)
Adverse Drug Reaction Bulletin     Full-text available via subscription   (Followers: 5)
AJP : The Australian Journal of Pharmacy     Full-text available via subscription   (Followers: 8)
Alternatives to Laboratory Animals     Full-text available via subscription   (Followers: 9)
American Journal of Cardiovascular Drugs     Hybrid Journal   (Followers: 19)
American Journal of Drug Discovery and Development     Open Access   (Followers: 3)
American Journal of Health-System Pharmacy     Full-text available via subscription   (Followers: 55)
American Journal of Pharmacological Sciences     Open Access   (Followers: 1)
American Journal of Pharmacology and Toxicology     Open Access   (Followers: 23)
American Journal of Therapeutics     Hybrid Journal   (Followers: 13)
Analytical Methods     Hybrid Journal   (Followers: 8)
Annales Pharmaceutiques Francaises     Full-text available via subscription  
Annals of Pharmacotherapy     Hybrid Journal   (Followers: 56)
Annual Review of Pharmacology and Toxicology     Full-text available via subscription   (Followers: 37)
Anti-Infective Agents     Hybrid Journal   (Followers: 5)
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry     Hybrid Journal   (Followers: 5)
Antibiotics     Open Access   (Followers: 10)
Antibody Therapeutics     Open Access  
Antiviral Chemistry and Chemotherapy     Open Access   (Followers: 1)
Antiviral Research     Hybrid Journal   (Followers: 8)
Applied Clinical Trials     Full-text available via subscription   (Followers: 7)
Archiv der Pharmazie     Hybrid Journal   (Followers: 3)
Archives of Drug Information     Hybrid Journal   (Followers: 4)
Archives of Pharmacal Research     Full-text available via subscription   (Followers: 2)
Archives of Pharmacy and Pharmaceutical Sciences     Open Access   (Followers: 1)
Archives of Razi Institute     Open Access  
Archivos Venezolanos de Farmacología y Terapéutica     Open Access  
Ars Pharmaceutica     Open Access  
Asian Journal of Medical and Pharmaceutical Researches     Open Access  
Asian Journal of Pharmaceutical Research and Health Care     Open Access   (Followers: 2)
Asian Journal of Pharmaceutical Sciences     Open Access   (Followers: 1)
Asian Journal of Pharmaceutics     Open Access   (Followers: 1)
Asian Journal of Research in Medical and Pharmaceutical Sciences     Open Access  
ASSAY and Drug Development Technologies     Hybrid Journal   (Followers: 3)
Australian Journal of Herbal Medicine     Full-text available via subscription   (Followers: 4)
Australian Pharmacist     Full-text available via subscription   (Followers: 7)
Autonomic & Autacoid Pharmacology     Hybrid Journal  
Avicenna Journal of Phytomedicine     Open Access   (Followers: 1)
Bangladesh Journal of Pharmacology     Open Access  
Bangladesh Journal of Physiology and Pharmacology     Open Access  
Bangladesh Pharmaceutical Journal     Full-text available via subscription  
Basic & Clinical Pharmacology & Toxicology     Hybrid Journal   (Followers: 14)
Behavioural Pharmacology     Hybrid Journal   (Followers: 2)
Bioanalysis     Full-text available via subscription   (Followers: 11)
Biochemical Pharmacology     Hybrid Journal   (Followers: 11)
BioDrugs     Full-text available via subscription   (Followers: 8)
Biological & Pharmaceutical Bulletin     Full-text available via subscription   (Followers: 3)
Biomarkers in Drug Development     Partially Free   (Followers: 2)
Biomaterials     Hybrid Journal   (Followers: 55)
Biomedical and Environmental Sciences     Full-text available via subscription   (Followers: 1)
Biomedicine & Pharmacotherapy     Full-text available via subscription   (Followers: 2)
Biometrical Journal     Hybrid Journal   (Followers: 9)
Biopharm International     Full-text available via subscription   (Followers: 20)
Biopharmaceutics and Drug Disposition     Hybrid Journal   (Followers: 11)
BMC Pharmacology     Open Access   (Followers: 2)
BMC Pharmacology & Toxicology     Open Access   (Followers: 8)
Brazilian Journal of Pharmaceutical Sciences     Open Access   (Followers: 1)
British Journal of Clinical Pharmacology     Hybrid Journal   (Followers: 30)
British Journal of Pharmacology     Hybrid Journal   (Followers: 17)
British Journal of Pharmacy (BJPharm)     Open Access   (Followers: 2)
Bulletin of Faculty of Pharmacy, Cairo University     Open Access   (Followers: 2)
CADTH Technology Overviews     Free  
Canadian Journal of Pain     Open Access   (Followers: 3)
Canadian Journal of Physiology and Pharmacology     Hybrid Journal   (Followers: 2)
Canadian Pharmacists Journal / Revue des Pharmaciens du Canada     Hybrid Journal   (Followers: 3)
Cancer Biotherapy & Radiopharmaceuticals     Hybrid Journal  
Cancer Chemotherapy and Pharmacology     Hybrid Journal   (Followers: 6)
Cardiovascular Drugs and Therapy     Hybrid Journal   (Followers: 14)
Cardiovascular Therapeutics     Open Access   (Followers: 3)
Cephalalgia Reports     Open Access  
Chemical and Pharmaceutical Bulletin     Full-text available via subscription   (Followers: 1)
Chemical Research in Toxicology     Hybrid Journal   (Followers: 22)
ChemMedChem     Hybrid Journal   (Followers: 11)
Chemotherapy     Full-text available via subscription   (Followers: 3)
Chinese Herbal Medicines     Full-text available via subscription   (Followers: 1)
Chinese Journal of Pharmaceutical Analysis     Full-text available via subscription  
Ciencia e Investigación     Open Access  
Ciência Equatorial     Open Access  
Clinical and Experimental Pharmacology and Physiology     Hybrid Journal   (Followers: 7)
Clinical and Translational Science     Open Access   (Followers: 4)
Clinical Complementary Medicine and Pharmacology     Open Access  
Clinical Drug Investigation     Full-text available via subscription   (Followers: 8)
Clinical Medicine Insights : Therapeutics     Open Access  
Clinical Neuropharmacology     Hybrid Journal   (Followers: 2)
Clinical Pharmacist     Partially Free   (Followers: 12)
Clinical Pharmacokinetics     Full-text available via subscription   (Followers: 28)
Clinical Pharmacology & Therapeutics     Hybrid Journal   (Followers: 46)
Clinical Pharmacology in Drug Development     Hybrid Journal   (Followers: 4)
Clinical Pharmacology: Advances and Applications     Open Access   (Followers: 6)
Clinical Research and Regulatory Affairs     Hybrid Journal   (Followers: 12)
Clinical Therapeutics     Hybrid Journal   (Followers: 35)
Clinical Toxicology     Hybrid Journal   (Followers: 19)
Clinical Trials     Hybrid Journal   (Followers: 19)
CNS Drug Reviews     Open Access   (Followers: 4)
CNS Drugs     Full-text available via subscription   (Followers: 10)
Combination Products in Therapy     Open Access  
Consultant Pharmacist     Full-text available via subscription   (Followers: 2)
Consumer Drugs     Full-text available via subscription  
Contract Pharma     Full-text available via subscription  
Cosmetics     Open Access   (Followers: 4)
CPT : Pharmacometrics & Systems Pharmacology     Open Access   (Followers: 10)
Critical Reviews in Clinical Laboratory Sciences     Hybrid Journal   (Followers: 19)
Critical Reviews in Therapeutic Drug Carrier Systems     Full-text available via subscription   (Followers: 5)
Critical Reviews in Toxicology     Hybrid Journal   (Followers: 26)
Current Bioactive Compounds     Hybrid Journal  
Current Cancer Therapy Reviews     Hybrid Journal   (Followers: 5)
Current Clinical Pharmacology     Hybrid Journal   (Followers: 4)
Current Drug Delivery     Hybrid Journal   (Followers: 6)
Current Drug Discovery Technologies     Hybrid Journal   (Followers: 6)
Current Drug Metabolism     Hybrid Journal   (Followers: 5)
Current Drug Safety     Hybrid Journal   (Followers: 8)
Current Drug Targets     Hybrid Journal   (Followers: 5)
Current Drug Therapy     Hybrid Journal   (Followers: 3)
Current Enzyme Inhibition     Hybrid Journal   (Followers: 1)
Current Issues in Pharmacy and Medical Sciences     Open Access   (Followers: 2)
Current Medical Science     Hybrid Journal  
Current Medicinal Chemistry     Hybrid Journal   (Followers: 13)
Current Molecular Pharmacology     Hybrid Journal  
Current Nanoscience     Hybrid Journal  
Current Neuropharmacology     Hybrid Journal   (Followers: 1)
Current Opinion in Pharmacology     Hybrid Journal   (Followers: 9)
Current Pharmaceutical Analysis     Hybrid Journal   (Followers: 1)
Current Pharmaceutical Biotechnology     Hybrid Journal   (Followers: 10)
Current Pharmaceutical Design     Hybrid Journal   (Followers: 11)
Current Pharmacogenomics and Personalized Medicine     Hybrid Journal   (Followers: 3)
Current Pharmacology Reports     Hybrid Journal  
Current Protocols in Pharmacology     Hybrid Journal  
Current Radiopharmaceuticals     Hybrid Journal   (Followers: 1)
Current Research in Drug Discovery     Open Access   (Followers: 1)
Current Research in Pharmacology and Drug Discovery     Open Access   (Followers: 1)
Current Therapeutic Research     Open Access   (Followers: 6)
Current trends in Biotechnology and Pharmacy     Open Access   (Followers: 8)
Current Vascular Pharmacology     Hybrid Journal   (Followers: 4)
Dhaka University Journal of Pharmaceutical Sciences     Open Access  
Die Pharmazie - An International Journal of Pharmaceutical Sciences     Full-text available via subscription   (Followers: 6)
Dose-Response     Open Access  
Drug and Chemical Toxicology     Hybrid Journal   (Followers: 14)
Drug and Therapeutics Bulletin     Hybrid Journal   (Followers: 9)
Drug Delivery     Open Access   (Followers: 9)
Drug Delivery and Translational Research     Hybrid Journal   (Followers: 2)
Drug Design, Development and Therapy     Open Access   (Followers: 3)
Drug Development and Industrial Pharmacy     Hybrid Journal   (Followers: 30)
Drug Development Research     Hybrid Journal   (Followers: 13)
Drug Discovery Today: Technologies     Full-text available via subscription   (Followers: 13)
Drug Metabolism and Disposition     Hybrid Journal   (Followers: 13)
Drug Metabolism and Pharmacokinetics     Hybrid Journal   (Followers: 6)
Drug Metabolism Letters     Hybrid Journal   (Followers: 3)
Drug Metabolism Reviews     Hybrid Journal   (Followers: 8)
Drug Research     Hybrid Journal   (Followers: 3)
Drug Resistance Updates     Hybrid Journal   (Followers: 3)
Drug Safety     Full-text available via subscription   (Followers: 82)
Drug Safety - Case Reports     Open Access   (Followers: 2)
Drug Target Insights     Open Access  
Drug, Healthcare and Patient Safety     Open Access   (Followers: 10)
Drugs     Full-text available via subscription   (Followers: 116)
Drugs & Aging     Full-text available via subscription   (Followers: 9)
Drugs & Therapy Perspectives     Full-text available via subscription   (Followers: 9)
Drugs : Real World Outcomes     Hybrid Journal   (Followers: 1)
Drugs and Therapy Studies     Open Access  
Drugs in R & D     Full-text available via subscription   (Followers: 2)
Drugs of the Future     Full-text available via subscription   (Followers: 8)
East and Central African Journal of Pharmaceutical Sciences     Open Access   (Followers: 1)
Egyptian Pharmaceutical Journal     Open Access  
EJNMMI Radiopharmacy and Chemistry     Open Access  
EMC - Cosmetologia Medica e Medicina degli Inestetismi Cutanei     Full-text available via subscription  
Emerging Trends in Drugs, Addictions, and Health     Open Access  
Environmental Toxicology and Pharmacology     Hybrid Journal   (Followers: 9)
Epilepsy Research     Hybrid Journal   (Followers: 7)
Ethiopian Pharmaceutical Journal     Full-text available via subscription   (Followers: 1)
EUREKA : Health Sciences     Open Access  
European Journal of Clinical Pharmacology     Hybrid Journal   (Followers: 14)
European Journal of Drug Metabolism and Pharmacokinetics     Hybrid Journal   (Followers: 8)
European Journal of Hospital Pharmacy : Science and Practice (EJHP)     Hybrid Journal   (Followers: 5)
European Journal of Medicinal Plants     Open Access   (Followers: 2)
European Journal of Pharmaceutical Sciences     Hybrid Journal   (Followers: 85)
European Journal of Pharmaceutics and Biopharmaceutics     Hybrid Journal   (Followers: 35)
European Journal of Pharmacology     Hybrid Journal   (Followers: 9)
European Neuropsychopharmacology     Hybrid Journal   (Followers: 8)
European Review for Medical and Pharmacological Sciences     Full-text available via subscription   (Followers: 1)
Experimental and Clinical Psychopharmacology     Full-text available via subscription   (Followers: 7)
Expert Opinion on Drug Delivery     Hybrid Journal   (Followers: 18)
Expert Opinion on Drug Discovery     Hybrid Journal   (Followers: 18)

        1 2 3 | Last   [Sort by number of followers]   [Restore default list]

Similar Journals
Journal Cover
Expert Opinion on Investigational Drugs
Journal Prestige (SJR): 1.166
Citation Impact (citeScore): 3
Number of Followers: 17  
 
Hybrid Journal Hybrid journal   * Containing 5 Open Access Open Access article(s) in this issue *
ISSN (Print) 1354-3784 - ISSN (Online) 1744-7658
Published by Taylor and Francis Homepage  [2648 journals]
  • Pharmacokinetics, safety, and tolerability of TQC3564, a novel CRTh2
           receptor antagonist: report of the first-in-human single- and
           multiple-dose escalation trials in healthy Chinese subjects

    • Free pre-print version: Loading...

      Authors: Xiaojiao Li, Qianqian Li, Tianliang Ji, Hong Zhang, Jingrui Liu, Min Wu, Hong Chen, Jinfeng Lou, Chengjiao Liu, Zhongnan Xu, Yanhua Ding
      Pages: 1 - 8
      Abstract: .

      Citation: Expert Opinion on Investigational Drugs
      PubDate: 2022-05-18T07:19:29Z
      DOI: 10.1080/13543784.2022.2078192
       
  • Adenosine pathway inhibitors: novel investigational agents for the
           treatment of metastatic breast cancer

    • Free pre-print version: Loading...

      Authors: Alessandro Rizzo, Raffaella Massafra, Annarita Fanizzi, Lucia Rinaldi, Antonio Cusmai, Agnese Latorre, Gian Maria Zaccaria, Maria Ronchi, Michele Telegrafo, Gennaro Gadaleta-Caldarola, Francesco Giotta, Vito Lorusso, Gennaro Palmiotti
      Pages: 1 - 7
      Abstract: .

      Citation: Expert Opinion on Investigational Drugs
      PubDate: 2022-05-18T07:19:09Z
      DOI: 10.1080/13543784.2022.2078191
       
  • Investigational drugs for ischemic stroke: what’s in the clinical
           development pipeline for acute phase and prevention'

    • Free pre-print version: Loading...

      Authors: Maria Giulia Mosconi, Maurizio Paciaroni, Walter Ageno
      Pages: 1 - 23
      Abstract: .

      Citation: Expert Opinion on Investigational Drugs
      PubDate: 2022-05-13T07:15:39Z
      DOI: 10.1080/13543784.2022.2072725
       
  • Investigational drugs for immune thrombocytopenia

    • Free pre-print version: Loading...

      Authors: Drew Provan, Adrian C Newland
      Pages: 1 - 13
      Abstract: .

      Citation: Expert Opinion on Investigational Drugs
      PubDate: 2022-05-11T07:19:46Z
      DOI: 10.1080/13543784.2022.2075340
       
  • Novel immunotherapy combinations in clinical trials for hepatocellular
           carcinoma: will they shape the future treatment landscape'

         This is an Open Access Article Open Access Article

    • Free pre-print version: Loading...

      Authors: Claudia Angela Maria Fulgenzi, Antonio D’Alessio, Olabisi Ogunbiyi, Coskun O. Demirtas, Alessandra Gennari, Alessio Cortellini, Rohini Sharma, David James Pinato
      Pages: 1 - 11
      Abstract: .

      Citation: Expert Opinion on Investigational Drugs
      PubDate: 2022-05-06T12:06:51Z
      DOI: 10.1080/13543784.2022.2072726
       
  • PARP inhibitors as single agents and in combination therapy: the most
           promising treatment strategies in clinical trials for BRCA-mutant ovarian
           and triple-negative breast cancers

    • Free pre-print version: Loading...

      Authors: Linjie Luo, Khandan Keyomarsi
      Pages: 1 - 25
      Abstract: .

      Citation: Expert Opinion on Investigational Drugs
      PubDate: 2022-05-03T03:14:33Z
      DOI: 10.1080/13543784.2022.2067527
       
  • Clinical development of antibody-drug conjugates in triple negative breast
           cancer: can we jump higher'

    • Free pre-print version: Loading...

      Authors: Dimitrios Zardavas
      Pages: 1 - 12
      Abstract: .

      Citation: Expert Opinion on Investigational Drugs
      PubDate: 2022-05-02T03:48:59Z
      DOI: 10.1080/13543784.2022.2070064
       
  • Heart failure with preserved ejection fraction: key stumbling blocks for
           experimental drugs in clinical trials

    • Free pre-print version: Loading...

      Authors: Amanda Lloji, Jayakumar Sreenivasan, Joel Novograd, Wilbert S. Aronow, Stephen Pan, Gregg M. Lanier
      Pages: 1 - 12
      Abstract: .

      Citation: Expert Opinion on Investigational Drugs
      PubDate: 2022-04-27T11:38:17Z
      DOI: 10.1080/13543784.2022.2069009
       
  • A randomized, open-label, single-dose, two-cycle crossover study to
           evaluate the bioequivalence and safety of lenvatinib and Lenvima® in
           Chinese healthy subjects

    • Free pre-print version: Loading...

      Authors: Zhongnan Xu, Yanli Wang, Guangwen Liu, Jiahui Chen, Wanhua Wang, Yang Cheng, Qing Ren, Yingzi Cui, Wei Yang, Zhengzhi Liu, Xuesong Chen, Jinling Xue, Tianying Chang, Xinyao Qu, Shuang Yu, Yannan Zhou, Kaibo Xu, Zhengjie Su, Qiaohuan Deng, Yicheng Zhao, Haimiao Yang
      Pages: 1 - 10
      Abstract: .

      Citation: Expert Opinion on Investigational Drugs
      PubDate: 2022-04-19T11:19:30Z
      DOI: 10.1080/13543784.2022.2067528
       
  • Risdiplam: an investigational survival motor neuron 2 (SMN2) splicing
           modifier for spinal muscular atrophy (SMA)

         This is an Open Access Article Open Access Article

    • Free pre-print version: Loading...

      Authors: Theodora Markati, Gemma Fisher, Sithara Ramdas, Laurent Servais
      Pages: 1 - 11
      Abstract: .

      Citation: Expert Opinion on Investigational Drugs
      PubDate: 2022-04-11T01:08:17Z
      DOI: 10.1080/13543784.2022.2056836
       
  • CAR-T cell therapy for triple-negative breast cancer and other solid
           tumors: preclinical and clinical progress

    • Free pre-print version: Loading...

      Authors: Chiara Corti, Konstantinos Venetis, Elham Sajjadi, Lorenzo Zattoni, Giuseppe Curigliano, Nicola Fusco
      Pages: 1 - 13
      Abstract: .

      Citation: Expert Opinion on Investigational Drugs
      PubDate: 2022-03-24T08:38:36Z
      DOI: 10.1080/13543784.2022.2054326
       
  • Repurposing tetracyclines for acute respiratory distress syndrome (ARDS)
           and severe COVID-19: a critical discussion of recent publications

    • Free pre-print version: Loading...

      Authors: Jose Garrido-Mesa, Kate Adams, Julio Galvez, Natividad Garrido-Mesa
      Pages: 1 - 8
      Abstract: .

      Citation: Expert Opinion on Investigational Drugs
      PubDate: 2022-03-23T08:29:43Z
      DOI: 10.1080/13543784.2022.2054325
       
  • Tucatinib: an investigational novel therapeutic agent for the treatment of
           HER-2 colorectal cancer

    • Free pre-print version: Loading...

      Authors: Daniel Ahn, Daniel Walden, Tanios Bekaii-Saab
      Pages: 1 - 5
      Abstract: .

      Citation: Expert Opinion on Investigational Drugs
      PubDate: 2022-03-17T09:31:57Z
      DOI: 10.1080/13543784.2022.2053107
       
  • KSI-301: an investigational anti-VEGF biopolymer conjugate for retinal
           diseases

    • Free pre-print version: Loading...

      Authors: Hudson D. Stern, Rehan M Hussain
      Pages: 1 - 7
      Abstract: .

      Citation: Expert Opinion on Investigational Drugs
      PubDate: 2022-03-16T07:50:31Z
      DOI: 10.1080/13543784.2022.2052042
       
  • Why does survival of hepatocellular carcinoma patients remain so low'
           Key stumbling blocks and questions in preclinical and clinical development
           

    • Free pre-print version: Loading...

      Authors: Margherita Rimini, Nicole Liscia, Valentina Burgio, Andrea Casadei-Gardini
      Pages: 1 - 12
      Abstract: .

      Citation: Expert Opinion on Investigational Drugs
      PubDate: 2022-03-16T05:17:05Z
      DOI: 10.1080/13543784.2022.2053108
       
  • Progress and pitfalls in the use of immunotherapy for patients with triple
           negative breast cancer

    • Free pre-print version: Loading...

      Authors: Elisa Agostinetto, Agnese Losurdo, Guilherme Nader-Marta, Armando Santoro, Kevin Punie, Romualdo Barroso, Lazar Popovic, Cinzia Solinas, Marleen Kok, Evandro de Azambuja, Matteo Lambertini
      Pages: 1 - 25
      Abstract: .

      Citation: Expert Opinion on Investigational Drugs
      PubDate: 2022-03-09T04:10:28Z
      DOI: 10.1080/13543784.2022.2049232
       
  • Ladiratuzumab vedotin for metastatic triple negative cancer: preliminary
           results, key challenges, and clinical potential

    • Free pre-print version: Loading...

      Authors: Alessandro Rizzo, Antonio Cusmai, Silvana Acquafredda, Lucia Rinaldi, Gennaro Palmiotti
      Pages: 1 - 4
      Abstract: .

      Citation: Expert Opinion on Investigational Drugs
      PubDate: 2022-02-18T02:10:18Z
      DOI: 10.1080/13543784.2022.2042252
       
  • A randomized, adaptive design, double-blind, 3-arm, parallel study
           assessing the pharmacokinetics and safety of AVT02, a high-concentration
           (100 mg/mL) Adalimumab biosimilar, in healthy adult subjects (ALVOPAD
           FIRST)

         This is an Open Access Article Open Access Article

    • Free pre-print version: Loading...

      Authors: Christopher Wynne, Christian Schwabe, Charlotte Lemech, Heimo Stroissnig, Roshan Dias, Joanna Sobierska, Eric Guenzi, Hendrik Otto, Abid Sattar, Richard Kay, Halimu N. Haliduola, Fausto Berti
      Pages: 1 - 12
      Abstract: .

      Citation: Expert Opinion on Investigational Drugs
      PubDate: 2022-02-10T02:25:59Z
      DOI: 10.1080/13543784.2022.2035359
       
  • Immune-based combinations for metastatic triple negative breast cancer in
           clinical trials: current knowledge and therapeutic prospects

    • Free pre-print version: Loading...

      Authors: Alessandro Rizzo, Angela Dalia Ricci, Laura Lanotte, Lucia Lombardi, Alessandro Di Federico, Giovanni Brandi, Gennaro Gadaleta-Caldarola
      Pages: 1 - 9
      Abstract: .

      Citation: Expert Opinion on Investigational Drugs
      PubDate: 2021-12-14T06:51:51Z
      DOI: 10.1080/13543784.2022.2009456
       
  • Biomarkers for breast cancer immunotherapy: PD-L1, TILs, and beyond

    • Free pre-print version: Loading...

      Authors: Alessandro Rizzo, Angela Dalia Ricci
      Pages: 1 - 7
      Abstract: .

      Citation: Expert Opinion on Investigational Drugs
      PubDate: 2021-11-25T02:31:12Z
      DOI: 10.1080/13543784.2022.2008354
       
  • A randomized, double-blind, placebo-controlled, single, and multiple
           dose-escalation Phase I clinical trial to investigate the safety,
           pharmacokinetic, and pharmacodynamic profiles of oral S086, a novel
           angiotensin receptor-neprilysin inhibitor, in healthy Chinese volunteers

    • Free pre-print version: Loading...

      Authors: Yue Hu, Hong Zhang, Xiaojiao Li, Jiajia Mai, Lizhi Yang, Jie Yan, Ying Li, Jingchao Sun, Wenjie Xu, Shiying He, Jinfeng Li, Min Wu
      Pages: 1 - 9
      Abstract: .

      Citation: Expert Opinion on Investigational Drugs
      PubDate: 2021-11-08T08:05:02Z
      DOI: 10.1080/13543784.2021.1985464
       
  • Latest generation estrogen receptor degraders for the treatment of hormone
           receptor-positive breast cancer

         This is an Open Access Article Open Access Article

    • Free pre-print version: Loading...

      Authors: Ya-Chi Chen, Jiajie Yu, Ciara Metcalfe, Tom De Bruyn, Thomas Gelzleichter, Vikram Malhi, Pablo D. Perez-Moreno, Xiaojing Wang
      Pages: 1 - 15
      Abstract: .

      Citation: Expert Opinion on Investigational Drugs
      PubDate: 2021-10-25T05:54:34Z
      DOI: 10.1080/13543784.2021.1983542
       
  • The emerging role of immune checkpoint inhibitors for the treatment of
           breast cancer

         This is an Open Access Article Open Access Article

    • Free pre-print version: Loading...

      Authors: Frederick M. Howard, Dario Villamar, Gong He, Alexander T. Pearson, Rita Nanda
      Pages: 1 - 18
      Abstract: .

      Citation: Expert Opinion on Investigational Drugs
      PubDate: 2021-10-12T03:22:05Z
      DOI: 10.1080/13543784.2022.1986002
       
  • Hepatitis D virus (HDV): investigational therapeutic agents in clinical
           trials

    • Free pre-print version: Loading...

      Authors: Bilal Asif, Christopher Koh
      Pages: 1 - 16
      Abstract: .

      Citation: Expert Opinion on Investigational Drugs
      PubDate: 2021-10-01T08:34:15Z
      DOI: 10.1080/13543784.2021.1977795
       
  • Investigational immunomodulatory drugs for enhancement of triple negative
           breast cancer (TNBC) immunotherapy: early phase development

    • Free pre-print version: Loading...

      Authors: Paolo Tarantino, Gabriele Antonarelli, Liliana Ascione, Giuseppe Curigliano
      Pages: 1 - 15
      Abstract: .

      Citation: Expert Opinion on Investigational Drugs
      PubDate: 2021-09-27T05:54:15Z
      DOI: 10.1080/13543784.2021.1972968
       
  • Giant cell arteritis: what is new in the preclinical and early clinical
           development pipeline'

    • Free pre-print version: Loading...

      Authors: Patricia Harkins, Richard Conway
      Pages: 1 - 12
      Abstract: .

      Citation: Expert Opinion on Investigational Drugs
      PubDate: 2021-06-30T01:36:43Z
      DOI: 10.1080/13543784.2021.1940949
       
 
JournalTOCs
School of Mathematical and Computer Sciences
Heriot-Watt University
Edinburgh, EH14 4AS, UK
Email: journaltocs@hw.ac.uk
Tel: +00 44 (0)131 4513762
 


Your IP address: 35.172.111.71
 
Home (Search)
API
About JournalTOCs
News (blog, publications)
JournalTOCs on Twitter   JournalTOCs on Facebook

JournalTOCs © 2009-